Detalhe da pesquisa
1.
Cytochrome P450 1A1 (CYP1A1) Gene Polymorphisms and Susceptibility to Breast Cancer: a Meta-Analysis in the Chinese Population.
Clin Lab
; 63(1): 67-72, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28164497
2.
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody.
Breast
; 72: 103597, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944341
3.
Significant response to the combination of pyrotinib and letrozole in a patient with metastatic HER2-positive and hormone receptor-positive breast cancer: a case report.
Ann Palliat Med
; 10(9): 10124-10129, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628933
4.
In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer.
Pathol Oncol Res
; 26(4): 2435-2442, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557169
5.
FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients.
Ther Adv Med Oncol
; 12: 1758835920915305, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499836
6.
Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance.
EBioMedicine
; 32: 111-118, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29807833